TSS
ATHE

Two Sigma Securities’s Alterity Therapeutics ATHE Stock Holding History

Two Sigma Securities’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,319
Closed -$10K – 2559
2022
Q3 		$10K Buy
+2,319
New +$13.6K ﹤0.01% 2398
2022
Q2 		– Sell
-1,021
Closed -$8K – 2206
2022
Q1 		$8K Sell
1,021
-994
-49% -$8.26K ﹤0.01% 2051
2021
Q4 		$15K Buy
2,015
+404
+25% +$4.38K ﹤0.01% 1438
2021
Q3 		$20K Buy
+1,611
New +$22.4K ﹤0.01% 1460
2018
Q3 		– Sell
-1,172
Closed -$22K – 2567
2018
Q2 		$22K Buy
+1,172
New +$23.3K ﹤0.01% 2556
2015
Q4 		– Sell
-372
Closed -$20K – 271
2015
Q3 		$20K Buy
+372
New +$23.6K 0.03% 180

Other funds holding ATHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $613M AUM 17.83% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

Two Sigma Securities's ATHE Position: Q4 2022 in Review

Two Sigma Securities sold out of Alterity Therapeutics (ATHE) in Q4 2022, closing a stake of 2,319 shares — an estimated $10K sold.

Two Sigma Securities first reported a position in ATHE in Q3 2015 and held it in 6 quarters. The position peaked at $22K in Q2 2018. 12 funds tracked by Wall St. Rank hold ATHE as of Q4 2022.

  • Two Sigma Securities reported no remaining Alterity Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 2,319 Alterity Therapeutics shares in Q4 2022, an estimated $10K.
  • Two Sigma Securities first reported a position in Alterity Therapeutics in Q3 2015 and held it in 6 quarters.
  • Two Sigma Securities's Alterity Therapeutics position peaked at $22K in Q2 2018.
  • 12 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.